6.
Nardi F, Basolo F, Crescenzi A, Fadda G, Frasoldati A, Orlandi F
. Italian consensus for the classification and reporting of thyroid cytology. J Endocrinol Invest. 2014; 37(6):593-9.
DOI: 10.1007/s40618-014-0062-0.
View
7.
Alshaikh S, Harb Z, Aljufairi E, Almahari S
. Classification of thyroid fine-needle aspiration cytology into Bethesda categories: An institutional experience and review of the literature. Cytojournal. 2018; 15:4.
PMC: 5841007.
DOI: 10.4103/cytojournal.cytojournal_32_17.
View
8.
Fernandes V, De Santis R, Enepekides D, Higgins K
. Surgeon-performed ultrasound guided fine-needle aspirate biopsy with report of learning curve; a consecutive case-series study. J Otolaryngol Head Neck Surg. 2015; 44:42.
PMC: 4625451.
DOI: 10.1186/s40463-015-0099-x.
View
9.
Tollin S, Mery G, Jelveh N, Fallon E, Mikhail M, BLUMENFELD W
. The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter. Thyroid. 2000; 10(3):235-41.
DOI: 10.1089/thy.2000.10.235.
View
10.
Gerhard R, da Cunha Santos G
. Inter- and intraobserver reproducibility of thyroid fine needle aspiration cytology: an analysis of discrepant cases. Cytopathology. 2007; 18(2):105-11.
DOI: 10.1111/j.1365-2303.2006.00430.x.
View
11.
Dhingra J
. Ultrasound-Guided Fine-Needle Biopsy of First 1000 Consecutive Thyroid Nodules: Single-Surgeon Experience. OTO Open. 2020; 4(2):2473974X20929008.
PMC: 7268147.
DOI: 10.1177/2473974X20929008.
View
12.
Gharib H, Papini E, Garber J, Duick D, Harrell R, Hegedus L
. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE. Endocr Pract. 2016; 22(5):622-39.
DOI: 10.4158/EP161208.GL.
View
13.
Wu H, Rose C, Elsheikh T
. The Bethesda system for reporting thyroid cytopathology: An experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy. Diagn Cytopathol. 2011; 40(5):399-403.
DOI: 10.1002/dc.21754.
View
14.
Cibas E, Ali S
. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017; 27(11):1341-1346.
DOI: 10.1089/thy.2017.0500.
View
15.
Russ G, Bonnema S, Erdogan M, Durante C, Ngu R, Leenhardt L
. European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS. Eur Thyroid J. 2017; 6(5):225-237.
PMC: 5652895.
DOI: 10.1159/000478927.
View
16.
Cibas E, Ali S
. The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009; 132(5):658-65.
DOI: 10.1309/AJCPPHLWMI3JV4LA.
View
17.
Bongiovanni M, Spitale A, Faquin W, Mazzucchelli L, Baloch Z
. The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol. 2012; 56(4):333-9.
DOI: 10.1159/000339959.
View
18.
Mondal S, Sinha S, Basak B, Roy D, Sinha S
. The Bethesda system for reporting thyroid fine needle aspirates: A cytologic study with histologic follow-up. J Cytol. 2013; 30(2):94-9.
PMC: 3701345.
DOI: 10.4103/0970-9371.112650.
View
19.
Haugen B, Alexander E, Bible K, Doherty G, Mandel S, Nikiforov Y
. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015; 26(1):1-133.
PMC: 4739132.
DOI: 10.1089/thy.2015.0020.
View
20.
Pinchera A
. Thyroid incidentalomas. Horm Res. 2008; 68 Suppl 5:199-201.
DOI: 10.1159/000110625.
View